UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000058153 |
|---|---|
| Receipt number | R000066414 |
| Scientific Title | Integrated Analysis of Cancer Molecular Profiling and Drug Discovery Research Using Quantum Computing |
| Date of disclosure of the study information | 2025/06/12 |
| Last modified on | 2025/06/11 09:54:02 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Integrated Research of Cancer Molecular Profiling and Drug Discovery Research Using Quantum Computing
Acronym
Q-MONSTAR_Project
Scientific Title
Integrated Analysis of Cancer Molecular Profiling and Drug Discovery Research Using Quantum Computing
Scientific Title:Acronym
Q-MONSTAR_Project
Region
| Japan |
Condition
Condition
Solid Malignancies
Classification by specialty
| Gastroenterology | Hepato-biliary-pancreatic medicine | Pneumology |
| Endocrinology and Metabolism | Hematology and clinical oncology | Nephrology |
| Neurology | Gastrointestinal surgery | Hepato-biliary-pancreatic surgery |
| Chest surgery | Endocrine surgery | Breast surgery |
| Obstetrics and Gynecology | Ophthalmology | Dermatology |
| Oto-rhino-laryngology | Orthopedics | Urology |
| Radiology | Neurosurgery |
Classification by malignancy
Malignancy
Genomic information
YES
Objectives
Narrative objectives1
This study aims to develop innovative approaches to discover novel biomarkers and optimize therapeutic strategies in cancer personalized medicine based on the utility of quantum computing technology by analyzing data obtained from the integrated database of SCRUM-Japan GI/ MONSTAR-SCREEN related research (SCRUM-MONSTAR integrated database) using quantum computing technology.
Basic objectives2
Others
Basic objectives -Others
Evaluating the Potential Applications of Quantum Computing Technology in Cancer Medicine
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Profiles of gene variants, biomarkers,in tumor tissue, blood, stool samples, images, etc.
Key secondary outcomes
Correlation between profiles of gene variants, biomarkers, etc. in tumour tissue, blood, stool samples, images, etc. and clinical pathological factors, clinical course, etc.
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
The analysis and secondary use of information obtained from the SCRUM-Japan GI MONSTAR-SCREEN Integrated Database for Biomarker Discovery in Malignant Tumours has not been refused in the relevant study.
Key exclusion criteria
The following criteria will result in exclusion from the study.
1) Data required for this study is missing.
2) The researcher determines that the participant is ineligible.
Target sample size
28500
Research contact person
Name of lead principal investigator
| 1st name | Takayuki |
| Middle name | |
| Last name | Yoshino |
Organization
National Cancer Center Hospital East
Division name
Drug Development and Promotion Division
Zip code
277-8577
Address
6-5-1, kahiwanoha, Kashiwa, Chiba
TEL
0471331111
tyoshino@east.ncc.go.jp
Public contact
Name of contact person
| 1st name | Mitsuho |
| Middle name | |
| Last name | Imai |
Organization
National Cancer Center Hospital East
Division name
Translational Research Support office, Department Drug Development/ International Research Promotion
Zip code
277-8577
Address
6-5-1, kahiwanoha, Kashiwa, Chiba
TEL
0471331111
Homepage URL
miim2@east.ncc.go.jp
Sponsor or person
Institute
National Cancer Center Hospital East
Institute
Department
Personal name
Funding Source
Organization
National Cancer Center Hospital East
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Cancer Center Hospital East
Address
6-5-1, kahiwanoha, Kashiwa, Chiba
Tel
0471331111
NCC_IRBoffice@ml.res.ncc.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 06 | Month | 12 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2025 | Year | 02 | Month | 27 | Day |
Date of IRB
| 2025 | Year | 03 | Month | 27 | Day |
Anticipated trial start date
| 2025 | Year | 03 | Month | 27 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Analyse biomarker information, including genetic abnormalities, from analysis data containing clinical information and genomic information integrated in the SCRUM-Japan GI/MONSTAR-SCREEN Integrated Database for Biomarker Discovery in Malignant Tumours.
Management information
Registered date
| 2025 | Year | 06 | Month | 12 | Day |
Last modified on
| 2025 | Year | 06 | Month | 11 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066414
